Cefiderocol is a novel siderophore-conjugated ?-lactam antibiotic which has been approved for clinical use. It demonstrated efficacy against infections caused by Gram-negative bacteria, including carbapenem-resistant strains. Novel antibiotics are rarely brought to market and, as such, ideal candidates therapeutic drug monitoring enables optimised dosing across range of scenarios whilst also re...